Dallah Healthcare Co (SAU:4004) Interest Expense : ﷼-105 Mil (TTM As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Dallah Healthcare Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Dallah Healthcare Co's interest expense for the three months ended in Mar. 2024 was ﷼ -29 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ﷼-105 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Dallah Healthcare Co's Operating Income for the three months ended in Mar. 2024 was ﷼ 147 Mil. Dallah Healthcare Co's Interest Expense for the three months ended in Mar. 2024 was ﷼ -29 Mil. Dallah Healthcare Co's Interest Coverage for the quarter that ended in Mar. 2024 was 5.09. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Dallah Healthcare Co Interest Expense Historical Data

The historical data trend for Dallah Healthcare Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dallah Healthcare Co Interest Expense Chart

Dallah Healthcare Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-25.10

-25.40

-41.84

-70.49

-104.14

Dallah Healthcare Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-28.50	-29.88	-22.64	-23.12	-28.96

Dallah Healthcare Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼-105 Mil.

Dallah Healthcare Co (SAU:4004) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Dallah Healthcare Co's Interest Expense for the three months ended in Mar. 2024 was ﷼-29 Mil. Its Operating Income for the three months ended in Mar. 2024 was ﷼147 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ﷼1,307 Mil.

Dallah Healthcare Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	147.479	/	-28.957
	=	5.09

The higher the ratio, the stronger the company's financial strength is.

Dallah Healthcare Co (SAU:4004) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dallah Healthcare Co (SAU:4004) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1157 King Fahad Road, Nakheel building, 2nd Floor, Riyadh, SAU, 12381

Website

https://www.dallahhealth.com

Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing and maintaining the healthcare entities, wholesale medicines and retail of medical and surgical equipment, prosthetics and devices for the disabled, hospital equipment and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants and the packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Service/Medicine and Pharmaceutical products. The majority of the company's revenue is earned from the Medical service segment.

Dallah Healthcare Co (SAU:4004) Headlines

No Headlines